Recommendations & Conclusions
7 items
2
Recommendation
Eleventh Report - The rollout of the CO…
Accepted
Comparatively low vaccination uptake persists in many vulnerable groups and, after the first booster campaign, has even dropped further for some. Overall uptake of COVID-vaccination has been high, reaching 90% of adults by the end of May 2022 (based on 2 doses). But some groups have seen much lower uptake. …
Government response. NHS England, supported by UKHSA, will evaluate approaches to vaccine delivery and work with local systems to continue evaluating different approaches to vaccine delivery, especially for communities where uptake and confidence may be lower. NHS England intends to continue offering …
HM Treasury
3
Recommendation
Eleventh Report - The rollout of the CO…
Accepted
NHS England has started planning for a reduction in vaccine sites and staffing for the rest of 2022 in anticipation of lower overall demand, but it is not yet clear how its strategy will strike the right balance between maintaining high 6 The rollout of the COVID-19 vaccine programme in …
Government response. The government agrees with the Committee’s recommendation and states that NHSE wrote to the Committee on 31 October 2022 to provide an update on the outcome of assurance of local plans.
HM Treasury
4
Recommendation
Eleventh Report - The rollout of the CO…
Accepted
There is considerable learning from the COVID-19 vaccine programme that might apply elsewhere, both in the health sector, such as screening programmes and routine vaccinations, and across wider government. In our March 2022 report on government preparedness for the pandemic, we noted the importance of learning lessons from the COVID-19 …
Government response. The government agreed to identify successes and lessons from the COVID-19 vaccine programme and communicate to the Committee the main improvements it will make as a result in other health programmes and wider government.
HM Treasury
7
Recommendation
Eleventh Report - The rollout of the CO…
Accepted
We were concerned that, in the week before the start of the new financial year, the Department had not finalised the allocation of its £9.6 billion Spending Review settlement for COVID-19 response activities, creating uncertainty for the vaccine programme. In the 2021 Spending Review, the Department received £9.6 billion for …
Government response. The government agrees with the recommendation and has set aside a minimum of around £2 billion of funding in the 2022-23 financial year for vaccine procurement and deployment against COVID-19. They plan to deliver a spring booster, roll out vaccinations …
HM Treasury
9
Conclusion
Eleventh Report - The rollout of the CO…
Accepted
Overall the evidence session indicated that officials were keen to learn lessons and saw clear potential benefits from doing so. However, it seemed likely to us that different organisations could be left to learn their own lessons and then to reach their own decisions about whether and to whom to …
Government response. The government agrees that there are lessons to be learned from the COVID-19 vaccine roll-out, and NHSE is leading development of an integrated immunisations strategy, and the department will write to the Committee setting out the main improvements being made …
HM Treasury
14
Recommendation
Eleventh Report - The rollout of the CO…
Accepted
We are most concerned about the comparatively low vaccination uptake that persists in many vulnerable groups and, after the first booster campaign, has actually widened in some. For example, compared to people of White British origin, people of Black, Black British and Pakistani origins were less than half as likely …
Government response. The government agreed to evaluate approaches for increasing vaccine uptake in vulnerable groups and support local areas in deploying the most effective approaches, including fresh approaches to tackle low uptake in some ethnic groups.
HM Treasury
30
Conclusion
Eleventh Report - The rollout of the CO…
Accepted
The week before the start of the new financial year, the Department had still not finalised the allocation of its £9.6 billion Spending Review settlement for COVID-19 response activities, creating uncertainty for the vaccine programme. In the 2021 Spending Review, the Department received £9.6 billion for all its key COVID-19 …
Government response. The government agrees with the Committee’s recommendation and has currently set aside a minimum of around £2 billion of funding in the 2022-23 financial year for vaccine procurement and deployment against COVID-19.
HM Treasury